References
Schupp M, Janke J, Clasen R, Unger T, Kintscher U. Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-γ activity. Circulation 2004;109:2054–2057.
Benson SC, Pershadsingh HA, Ho CI, Chittiboyina A, Desai P, Pravenec M, et al. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPAR gamma-modulating activity. Hypertension 2004;43:993–1002.
Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, et al. PPAR gamma ligands increase expression and plasma concentrations of adiponectin an adipose derived protein. Diabetes 2001;50:2094–2099.
Clasen R, Schupp M, Foryst-Ludwig A, Sprang C, Clemenz M, Krikov M, et al. PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin. Hypertension 2005;46:137–143.
Miura Y, Yamamoto N, Tsunekawa S, Taguchi S, Eguchi Y, Ozaki N, et al. Replacement of valsartan and candesartan by telmisartan in hypertensive patients with type 2 diabetes: metabolic and antiatherogenic consequences. Diabetes Care 2005;28:757–758.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Makita, S., Abiko, A., Naganuma, Y. et al. Potential Effects of Angiotensin II Receptor Blockers on Glucose Tolerance and Adiponectin Levels in Hypertensive Patients. Cardiovasc Drugs Ther 21, 317–318 (2007). https://doi.org/10.1007/s10557-007-6039-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10557-007-6039-x